Skip to main content

GSA CAPITAL PARTNERS LLP

Position in OCUL — Ocular Therapeutix, Inc

CIK 1362033 LONDON, X0

Position in OCUL

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$262,262
-$163,827 QoQ
Shares Held
26,707
-23.9% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#158
of 257 holders
Holding Since
Mar 2022
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OCUL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. OCUL ranks #117 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OCUL

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $262,262 26,707
2025-12-31 $426,089 35,098
2025-09-30 $1,350,814 115,553
2025-03-31 $112,192 15,306
2024-09-30 $1,102,124 126,681
2024-03-31 $261,543 28,741
2023-12-31 $1,101,187 246,903
2023-09-30 $733,447 233,582
2023-06-30 $613,797 118,953
2022-06-30 $514,471 127,978
2022-03-31 $285,219 57,620